In-vitro-induced Th17 cells fail to induce inflammation in vivo and show an impaired migration into inflamed sites.

Recently, IL-17 produced by Th17 cells was described as pro-inflammatory cytokine with an eminent role in autoimmune diseases, e.g. rheumatoid arthritis.